PEDIATRICS Vol. 79 No. 5 May 1987, pp. 842
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JORDAN, G. D.
Right arrow Articles by FRANK, C. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by JORDAN, G. D.
Right arrow Articles by FRANK, C. G.

Benzyl Alcohol in Neuromuscular Blocking Agents

GLENN D. JORDAN USA, MC1, NICHOLAS J. THEMELIS USA, MC1, SUSAN O. MESSERLY USA, MC1, ROBERT V. JARRETT USA, MC1, JOSE GARCIA USA, MC1, and C. GILBERT FRANK USA, MC1

1 Newborn Medicine Service, Madigan Army Medical Center, Tacoma, WA 98431-5473

In Reply.—

The comments of van der Hal et al serve to further underscore our concerns regarding the uncritical appropriation for use in neonates of pharmacologic agents belonging to the "adult" formulary. The issue is pervasive—the overwhelming preponderance of drugs used in neonatal intensive care settings are the adopted progeny of research into adult pathophysiology.

Following our initial identification of the risk of benzyl alcohol toxicity associated with continuous infusions of doxapram (Pediatrics 1986;78:540-541), we subjected to close scrutiny the formulation of all agents administered iv in our nursery.